Answer
Yes. Increased cholesterol is very common on blood testing, so lipid monitoring is required after treatment starts.
Sources for this answer
- Baricitinib Lilly — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.